These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1307651)

  • 1. Comparison of qualitative and quantitative blood determinations in stools of healthy persons and patients with colorectal tumours.
    Tomecki R; Ostrowski J
    Mater Med Pol; 1992; 24(3):185-9. PubMed ID: 1307651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the quantitative determination of blood in stools with the Hemoccult test in various digestive tract diseases].
    Tomecki R; Ostrowski J
    Wiad Lek; 1990 Jun; 43(11):489-94. PubMed ID: 2219913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal occult blood tests in occult gastrointestinal bleeding.
    Bond JH
    Semin Gastrointest Dis; 1999 Apr; 10(2):48-52. PubMed ID: 10361895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of occult blood in stools: comparison of three gaiac tests and a latex agglutination test.
    Favennec L; Kapel N; Meillet D; Chochillon C; Gobert JG
    Ann Biol Clin (Paris); 1992; 50(5):311-3. PubMed ID: 1485687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Occult fecal blood loss--comparison of immunochemical and biochemical tests].
    Dvorák M; Kocna P; Vanícková Z
    Cas Lek Cesk; 2002 Apr; 141(7):217-9. PubMed ID: 12053757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative Haemoccult test in malignant and premalignant lesions of the colon. Validation of the Haemoccult test with total colonoscopy.
    Kimmig JM; Strauch M; Hallen M
    Endoscopy; 1989 May; 21(3):136-40. PubMed ID: 2640543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of upper gastrointestinal blood with fecal occult blood tests.
    Rockey DC; Auslander A; Greenberg PD
    Am J Gastroenterol; 1999 Feb; 94(2):344-50. PubMed ID: 10022627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of immunochemical and biochemical methods for determination of occult fecal blood].
    Ferkl M; Kocna P; Fric P
    Cas Lek Cesk; 1992 Mar; 131(5):149-51. PubMed ID: 1581946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of calgranulin B in stools from the patients with colorectal cancer.
    Yoo BC; Shin YK; Lim SB; Hong SH; Jeong SY; Park JG
    Dis Colon Rectum; 2008 Nov; 51(11):1703-9. PubMed ID: 18584251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.
    Kim Y; Lee S; Park S; Jeon H; Lee W; Kim JK; Cho M; Kim M; Lim J; Kang CS; Han K
    Ann Clin Lab Sci; 2003; 33(1):32-8. PubMed ID: 12661896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
    Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer detection in the practice setting. Impact of fecal blood testing.
    Ahlquist DA; Klee GG; McGill DB; Ellesfon RD
    Arch Intern Med; 1990 May; 150(5):1041-5. PubMed ID: 2331185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early detection of colorectal cancers by detection of occult blood in feces using Krypto-Haem SSW].
    Uhlig K; Lampe J; Jacobasch KH
    Z Gesamte Inn Med; 1986 Dec; 41(23):660-3. PubMed ID: 3577258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon cancer screening strategies.
    Agrawal J; Syngal S
    Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal blood levels in health and disease. A study using HemoQuant.
    Ahlquist DA; McGill DB; Schwartz S; Taylor WF; Owen RA
    N Engl J Med; 1985 May; 312(22):1422-8. PubMed ID: 3873009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.